adagrasib,sotorasib
mirati therapeutics,amgen
['adagrasib', 'nsclc', 'sotorasib', 'sclc', 'arca, (-arcade)']
research (3431) from drs. skoulidis and negrao found that co-occurring mutations in keap1, smarca4 &amp; cdkn2a are linked with poor outcomes in patients with kras g12c-mutant nsclc treated with adagrasib or sotorasib: #aacr23 2/3
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789